Cargando…
Novel Multiplexed Assay for Identifying SH2 Domain Antagonists of STAT Family Proteins
Some of the signal transducer and activator of transcription (STAT) family members are constitutively activated in a wide variety of human tumors. The activity of STAT depends on their Src homology 2 (SH2) domain-mediated binding to sequences containing phosphorylated tyrosine. Thus, antagonizing th...
Autores principales: | Takakuma, Kazuyuki, Ogo, Naohisa, Uehara, Yutaka, Takahashi, Susumu, Miyoshi, Nao, Asai, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745430/ https://www.ncbi.nlm.nih.gov/pubmed/23977103 http://dx.doi.org/10.1371/journal.pone.0071646 |
Ejemplares similares
-
Inhibition of STAT3 by Anticancer Drug Bendamustine
por: Iwamoto, Kazunori, et al.
Publicado: (2017) -
Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity
por: Kashima, Hajime, et al.
Publicado: (2016) -
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain
por: Gabriele, Elena, et al.
Publicado: (2017) -
STX‐0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression
por: Makitani, Kouki, et al.
Publicado: (2020) -
Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppi
por: Okada, Yusuke, et al.
Publicado: (2018)